[Decreasing effect of DL-alpha-methylthyroxine-ethylester, D-thyroxine (DT4), D-triiodothyronine (DT3) and a combination of DT4 + DT3 on serum lipids in primary hyperlipoproteinemia Type IIa and b].
D003864:Depression, Chemical; D004359:Drug Therapy, Combination; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D008053:Lipid Mobilization / Q000187:drug effects; D008077:Lipoproteins, LDL / Q000097:blood*; D013974:Thyroxine / Q000627:therapeutic use*; D014284:Triiodothyronine / Q000627:therapeutic use*
D008077:Lipoproteins, LDL; D014284:Triiodothyronine; D013974:Thyroxine
Serum-lipdsenkende Wirkung von DL-alpha-Methylthyroxin-ethylester, D-Thyroxin (DT4), D-Trijodthyronin (DT3) und einer Kombination von DT4 + DT3 bei primären Hyperlipoproteinämien Typ IIa und b